Biotechnology
Sort by: Featured Most recent Most read Most commented
75 results total, viewing 41 - 50
Covidien brain monitor earns nod from NICE
Covidien PLC’s BIS Brain Monitoring System earned a recommendation from the U.K.-based National Institute for health and Clinical Excellence. more
| 11/23/12
Covidien earnings fall in 3Q
Medical technology maker Covidien Plc. reported third quarter earnings of $453 million, or 93 cents per diluted share, a drop of 15.3 percent from the $535 million, or $1.07 per diluted share reported during the same period in 2011. more
| 7/27/12
EpiVax creates recipe for novel vaccine approach to new flu strain
An analysis of the new strain of what’s being called Shanghai bird flu, conducted by Dr. Anne S. De Groot and her team of researchers at EpiVax Inc., has concluded that there may be the need to develop a new vaccine to combat a potential devastating outbreak of the disease. more
Amgen reaches deal to use Bind’s technology to seek cancer drugs
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences. more
Biomedical Structures announces facility expansion, new VP
Biomedical Structures LLC, a developer of biomedical textiles for medical devices, has expanded its medical textile development and manufacturing facilities and appointed a new vice president of research and development, the company announced Tuesday. more
| 1/8/13
Amgen to acquire deCode Genetics
Amgen Inc., one of the world’s largest biotechnology companies, has agreed to buy genetic-testing company deCode Genetics Inc. for $415 million, Amgen announced Monday. more
| 12/10/12
Lifespan opens stem cell research lab in Knowledge District
Lifespan opened a new stem cell research laboratory Wednesday afternoon on the fifth floor of the hospital network’s Coro Building. The lab is the first phase of a major investment to turn the entire building in Providence’s Knowledge District into a state-of-the art research facility. more
Amgen $150M Aranesp misbranding plea deal approved
(Updated, 10:45 a.m.) A federal judge accepted Amgen Inc.’s plea agreement on a charge that it misbranded its anemia drug Aranesp, putting to rest a five-year probe of the company’s marketing practices. more
Cumberland pharma firm moves to new office, lab in Mass.
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday. more
GRRL Tech exposes nearly 500 to STEM industries
More than 470 girls from local high schools spent Thursday at the University of Rhode Island exploring STEM industries and career pathways during Tech Collective’s 12th annual GRRL Tech event. more
« Prev | 1 … 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News